MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Novel Method of Surveillance in Barrett's Esophagus

Completed

Conditions: Barrett Esophagus

First Posted Date: 2009-08-07

Last Posted Date: 2009-09-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 180

Registration Number: NCT00955019

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Serum Procalcitonin

Completed

Conditions: Subarachnoid Hemorrhage (SAH)

First Posted Date: 2009-08-07

Last Posted Date: 2011-06-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT00954551

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

Phase 1

Completed

Conditions: Primary Sclerosing Cholangitis
Trisomy 7
Cholangiocarcinoma
Chemoprevention

Interventions: Drug: Erlotinib (Tarceva)

First Posted Date: 2009-08-07

Last Posted Date: 2014-01-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 6

Registration Number: NCT00955149

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Is Plasma Transfusion Beneficial Prior to Low-Risk Procedures in Hospitalized Patients With Blood Clotting Abnormalities?

Phase 3

Completed

Conditions: Blood Coagulation, Disorders
Surgical Procedures, Minimally Invasive

First Posted Date: 2009-08-06

Last Posted Date: 2009-11-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2

Registration Number: NCT00953901

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Lubiprostone, Colonic Motility and Sensation

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: lubiprostone
Drug: Placebo
Other: Bowel preparation

First Posted Date: 2009-08-06

Last Posted Date: 2012-02-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT00953043

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

B-type Natriuretic Peptide (BNP) in Human Hypertension

Phase 1

Terminated

Conditions: Hypertension Stage 1

First Posted Date: 2009-08-06

Last Posted Date: 2011-10-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8

Registration Number: NCT00953472

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Trial of Mesalamine for the Treatment of Active Microscopic Colitis

Phase 2

Completed

Conditions: Microscopic Colitis
Diarrhea

First Posted Date: 2009-08-06

Last Posted Date: 2011-05-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 70

Registration Number: NCT00952952

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Phase 2

Terminated

Conditions: Primary Sclerosing Cholangitis

Interventions: Drug: Thalidomide

First Posted Date: 2009-08-06

Last Posted Date: 2012-02-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT00953615

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Effects of LAF237 on Gastric Function in Type 2 Diabetes

Phase 3

Completed

Conditions: Diabetes Mellitus, Non-Insulin-Dependent

First Posted Date: 2009-08-06

Last Posted Date: 2011-03-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 18

Registration Number: NCT00952991

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Colesevelam
Other: Placebo
Behavioral: Diet
Drug: Metformin

First Posted Date: 2009-08-04

Last Posted Date: 2013-11-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 38

Registration Number: NCT00951899

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy